Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients

NCT02016859 is registered in ClinicalTrials.gov with Dr. Yishai Ofran as lead sponsor.

NCT NCT02016859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02016859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients
Lead sponsor
Dr. Yishai Ofran
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2014
Completion date
November 30, 2014
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill patients, neutropenic fever patients, patients with hip fractures